Skip to content

Modalis Therapeutics vs ToolGen Inc.

Modalis Therapeutics logo

Modalis Therapeutics

Modalis is an emerging biotech company that develops therapeutics using CRISPR based technology

23 employees · est. 2016 · Cambridge, United States

VS
ToolGen Inc. logo

ToolGen Inc.

Innovate Genome

29 employees · est. 1999 · Seoul, Korea South

ToolGen Inc. is the older company (2016 vs 1999).

Side-by-Side Comparison

Modalis Therapeutics ToolGen Inc.
Founded
2016 1999 older
Headquarters
Cambridge, United States Seoul, Korea South
Employees
23 29
Industry
Biotechnology, Health Care, Life Sciences Biotechnology, Life Sciences
Funding Stage
IPO Corporate Round
Total Funding
$934.72M Not tracked yet
Funding Rounds
7 2
Services
CRISPR-GNDM technology, epigenome editing, gene therapy development, genome editing solutions, therapeutic pipeline development Not tracked yet
Target Customers
patients with genetic disorders, pharmaceutical companies, healthcare providers, biomedical researchers Not tracked yet
Taxonomy
Biotech CompanyGenetic MedicinesCRISPR TechnologyEpigenetic Gene ModulationPrecision MedicineOrphan Genetic Diseases +9 Genome EditingCRISPRTherapeuticsResearch And DevelopmentGenetic EngineeringCell Line Editing +8
Website
modalistx.com toolgen.com
Modalis Therapeutics logo

About Modalis Therapeutics

Modalis Therapeutics, an emerging biotech company founded in 2016, is pioneering the development of therapeutics using CRISPR-based technology. The company's core offering revolves around its proprietary CRISPR-GNDM technology, which allows for precise gene expression and histone modification withou...

ToolGen Inc. logo

About ToolGen Inc.

ToolGen Inc. is a biotechnology and life sciences company based in South Korea, founded in 1999. The company's mission is to innovate genome by revolutionizing genome editing technology. Toolgen is dedicated to developing therapeutics not only for humans but also for plants and animals, by modifying...

Also comparing in this category

Comparing more than these two?

Get Modalis Therapeutics, ToolGen Inc. and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does Modalis Therapeutics compare?

A PDF of Modalis Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

Modalis Therapeutics was founded in 2016, based in Cambridge, United States, with 23 employees. Modalis Therapeutics, an emerging biotech company founded in 2016, is pioneering the development of therapeutics using CRISPR-based technology. The company's core offering revolves around its propriet. ToolGen Inc. was founded in 1999, based in Seoul, Korea South, with 29 employees. ToolGen Inc. is a biotechnology and life sciences company based in South Korea, founded in 1999. The company's mission is to innovate genome by revolutionizing genome editing technology.
Modalis Therapeutics has raised $934.72M and ToolGen Inc. no disclosed funding. Latest stage: Modalis Therapeutics IPO, ToolGen Inc. Corporate Round.
Both work in Biotechnology and Life Sciences.

Compare Modalis Therapeutics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Modalis Therapeutics on 11 Sep 2024, and ToolGen Inc. on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout